MISP promotes the progression of lung adenocarcinoma through Inhibition of the Hippo signaling pathway
{{output}}
Background: Globally, lung cancer is a malignant tumor with the highest morbidity and mortality rate, of which lung adenocarcinoma (LUAD) is the most common pathological type, accounting for about 40% of all cases. This study aim... ...
